Alzheimer’s disease (AD) is characterized by a spectrum of clinical and pathological features, encompassing synaptic loss, neuronal damage, alterations in plasticity, and the aggregation of senile plaques composed of Aβ and tau proteins, ultimately culminating in progressive neural system dysfunction over time (Valenza and Scuderi, 2022). This evidence concerns the gene MAPT and Alzheimer disease.